Latest Artificial Intelligence News

Hiremii Limited reports a modest 0.4% revenue increase to $7.5 million in Q2 FY25, underpinned by strategic AI platform deployment and expanding Energy Transition sector opportunities.

TrivarX has secured positive feedback from the FDA on its pivotal trial design for MEB-001, an AI-driven algorithm targeting major depressive episode screening via sleep study data. The company is advancing site collaborations to launch a large-scale US trial.

Legacy Minerals is ramping up exploration across its NSW portfolio, initiating large-scale geophysical surveys and updating mineral resource estimates, setting the stage for significant drilling campaigns in 2025.

Icetana Limited reports a challenging December quarter with declining revenues but secures significant new contracts and launches a fully underwritten $2.65 million rights issue.

BPH Energy Limited's December 2024 quarterly report reveals strategic capital placements and investments in hydrogen and medical technology, alongside ongoing regulatory challenges with the PEP-11 permit.

Augustus Minerals has reported exceptional high-grade gold assays up to 50.3g/t Au from rock chips at its Clifton East prospect within the Music Well project, reinforcing the area’s significant exploration potential. The company is advancing geological mapping and planning drilling, supported by an AI-driven targeting study due in Q1 2025.

Global Health Limited reported a robust 22% increase in customer receipts for the December 2024 quarter, alongside a significant improvement in operating cash flow, positioning the company well amid ongoing healthcare sector challenges.

Qoria Limited reports robust December quarter results for FY2025, driven by strong ARR growth, expanding global reach, and strategic AI innovations that promise to accelerate future growth.

Mirrabooka Investments Limited reported steady half-year profits with a portfolio return of 11.5%, comfortably outperforming its benchmark. The company raised its interim dividend by 12.5%, reflecting confidence in its small and mid-cap investment strategy despite cautious market conditions.